Sula Mazimba Selected Research

4-S-(propionic acid)sulfidocyclophosphamide (PASP)

4/2019

Right ventricular outflow tract velocity time integral-to-pulmonary artery systolic pressure ratio: a non-invasive metric of pulmonary arterial compliance differs across the spectrum of pulmonary hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sula Mazimba Research Topics

Disease

20	Heart Failure 11/2023 - 12/2010
4	Atrial Fibrillation 01/2024 - 09/2020
4	Cardiomyopathies (Cardiomyopathy) 10/2023 - 12/2010
3	Pulmonary Arterial Hypertension 01/2022 - 04/2019
3	Hemorrhage 11/2020 - 12/2019
2	Cardiogenic Shock 10/2022 - 11/2018
2	Cicatrix (Scar) 01/2022 - 12/2021
2	Pulmonary Hypertension 09/2021 - 11/2017
2	Hypertension (High Blood Pressure) 01/2020 - 01/2019
1	Coronary Disease (Coronary Heart Disease) 01/2024
1	Left Ventricular Dysfunction 01/2024
1	Morbid Obesity 11/2023
1	Obesity 11/2023
1	Respiratory Insufficiency (Respiratory Failure) 10/2022
1	COVID-19 10/2022
1	Gout 07/2022
1	Schistosomiasis (Bilharziasis) 04/2022
1	Pulmonary Embolism 01/2022
1	High Cardiac Output 01/2020
1	Primary Graft Dysfunction 12/2019
1	Inflammation (Inflammations) 12/2019
1	Inferior Wall Myocardial Infarction 05/2019
1	Airway Obstruction (Choking) 01/2019
1	Apnea 01/2019
1	Pulmonary Edema 01/2019
1	Stroke (Strokes) 01/2018
1	Familial Primary Pulmonary Hypertension 11/2017
1	Infections 09/2014
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2010
1	Multiple Myeloma 12/2010
1	Heart Diseases (Heart Disease) 12/2010
1	Cardiotoxicity 12/2010

Drug/Important Bio-Agent (IBA)

3	LY 165163 (PAPP)IBA 09/2021 - 12/2016
2	Natriuretic PeptidesIBA 11/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 04/2022 - 12/2019
2	Oxygen (Dioxygen)IBA 10/2020 - 01/2019
1	TicagrelorIBA 01/2024
1	Clopidogrel (Plavix)FDA Link 01/2024
1	high fluorescent intermediate IIIBA 11/2023
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2023
1	CreatinineIBA 09/2023
1	Colchicine FDA LinkGeneric 07/2022
1	Anti-Arrhythmia AgentsIBA 03/2022
1	riociguatIBA 01/2022
1	GadoliniumIBA 01/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	PlasticsIBA 01/2022
1	AntigensIBA 01/2020
1	Prostaglandins DIBA 12/2019
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 04/2019
1	CatecholaminesIBA 01/2019
1	Trastuzumab (Herceptin)FDA Link 12/2010
1	Bortezomib (Velcade)FDA Link 12/2010
1	Proteasome InhibitorsIBA 12/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 12/2010
1	AnthracyclinesIBA 12/2010
1	UbiquitinIBA 12/2010
1	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2010

Therapy/Procedure

12	Therapeutics 11/2023 - 12/2010
7	Heart-Assist Devices 10/2023 - 12/2016
5	Heart Transplantation (Grafting, Heart) 10/2023 - 09/2014
3	Catheters 10/2023 - 12/2016
3	Cardiac Resynchronization Therapy 09/2023 - 12/2020
3	Patient Readmission 10/2022 - 12/2016
3	Length of Stay 10/2022 - 12/2019
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 10/2022 - 09/2020
2	Critical Care (Surgical Intensive Care) 01/2022 - 01/2019
1	Percutaneous Coronary Intervention 10/2022
1	Extracorporeal Membrane Oxygenation 01/2022
1	Defibrillators (Defibrillator) 12/2020
1	Stents 11/2020
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2020
1	Hospital to Home Transition 03/2019
1	Perioperative Care 01/2019
1	Transplantation 12/2016